Özgür Akkaya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Özgür Akkaya has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Ümit Arslan
Department of Cardiovascular Surgery, Faculty of Medicine, Atatürk University, Erzurum 25030, Türkiye
3 shared publications - Ali Çoner
Department of Cardiology, Alanya Alaaddin Keykubat University Faculty of Medicine, Antalya, Türkiye
2 shared publications - Izatullah Jalalzai
Department of Cardiovascular Surgery, Faculty of Medicine, Atatürk University, Erzurum 25030, Türkiye
2 shared publications - Anil Gulcu
ALANYA ALAADDIN KEYKUBAT UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF SURGICAL MEDICINE, DEPARTMENT OF ORTHOPEDICS AND TRAUMATOLOGY
1 shared publication - Can Ramazan Oncel
Alanya Alaaddin Keykubat Üniversitesi
1 shared publication - Cemal Köseoğlu
Department of Cardiology, Alanya Alaaddin Keykubat University, Faculty of Medicine, Antalya, Türkiye
1 shared publication
Latest Publications
- 10 November 2026
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
Management of recurrent left atrial leiomyosarcoma
Primary cardiac leiomyosarcoma is an extremely rare malignancy often misdiagnosed as benign atrial myxoma. A 55-year-old male presented with syncope from a recurrent left atrial mass, eight months after initial resection for a presumed myxoma at another center. Redo median sternotomy and…
- 10 November 2026
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
Management of recurrent left atrial leiomyosarcoma
Primary cardiac leiomyosarcoma is an extremely rare malignancy often misdiagnosed as benign atrial myxoma. A 55-year-old male presented with syncope from a recurrent left atrial mass, eight months after initial resection for a presumed myxoma at another center. Redo median sternotomy and…
- Open Access
- 5 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8622
Reply to Vural, Ü. Comment on “Akkaya et al. Posterior Teflon-Felt-Reinforced Coronary Button Anastomosis in a Modified Bentall Procedure: Early Outcomes in a Single-Center Retrospective Study. J. Clin. Med. 2026, 15, 2546”
- 5 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8622
Open AccessReply to Vural, Ü. Comment on “Akkaya et al. Posterior Teflon-Felt-Reinforced Coronary Button Anastomosis in a Modified Bentall Procedure: Early Outcomes in a Single-Center Retrospective Study. J. Clin. Med. 2026, 15, 2546”
- Open Access
- 26 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (7) , 2546
Posterior Teflon-Felt-Reinforced Coronary Button Anastomosis in a Modified Bentall Procedure: Early Outcomes in a Single-Center Retrospective Study
Background: Coronary button reimplantation is a key determinant of operative safety in the modified Bentall procedure (MBP), and technical modifications aimed at improving anastomotic stability and hemostasis continue to evolve. This study investigated the early outcomes of a posterior Teflon-felt-reinforced coronary button technique in comparison with the conventional approach. Methods: Between January 2021 and May 2025, a total of 57 patients who underwent an elective modified Bentall procedure were included and divided into two groups: the conventional coronary button group (CCB, n = 30) and the posterior Teflon-felt-reinforced coronary button group (RCB, n = 27). Operative variables and early postoperative outcomes (including bleeding, re-exploration, and 30-day mortality) were compared between the two groups. Results: The CCB group included 9 women and 21 men with a mean age of 59.5 ± 9.6 years, whereas the RCB group consisted of 5 women and 22 men with a mean age of 57.3 ± 8.9 years. The mean maximum aortic root diameter was 49.6 ± 5.3 mm, and the mean ascending aortic diameter was 50.8 ± 4.9 mm. Aortic cross-clamp (ACC) and cardiopulmonary bypass (CPB) times were similar between the groups (p = 0.330 and p = 0.214, respectively). After excluding patients who underwent planned coronary artery bypass grafting (CABG; n = 8), the incidence of unplanned CABG was higher in the CCB group than in the RCB group [6 (24.0%) vs. 2 (8.3%); p = 0.136]. Postoperative 24-h chest tube drainage tended to be lower (p = 0.060), and re-exploration for bleeding occurred less frequently (11.1% vs. 30.0%, p = 0.076), with no coronary button-related bleeding after reinforcement. The RCB group required significantly fewer transfused blood products, including red blood cells, fresh frozen plasma, and platelets (all p < 0.01). Intensive care unit stay was shorter in the reinforced group (p < 0.01), with a trend toward reduced hospital stay (p = 0.085). Early mortality was comparable (p = 0.356). Conclusions: Posterior Teflon-felt-reinforced coronary button anastomosis may improve early hemostatic stability and provide additional mechanical support during coronary reimplantation in the modified Bentall procedure; confirmation in larger cohorts is required.
- 26 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (7) , 2546
Open AccessPosterior Teflon-Felt-Reinforced Coronary Button Anastomosis in a Modified Bentall Procedure: Early Outcomes in a Single-Center Retrospective Study
Background: Coronary button reimplantation is a key determinant of operative safety in the modified Bentall procedure (MBP), and technical modifications aimed at improving anastomotic stability and hemostasis continue to evolve. This study investigated the early outcomes of a posterior Teflon-felt-reinforced coronary button technique in comparison with the conventional approach. Methods: Between January 2021 and May 2025, a total of 57 patients who underwent an elective modified Bentall procedure were included and divided into two groups: the conventional coronary button group (CCB, n = 30) and the posterior Teflon-felt-reinforced coronary button group (RCB, n = 27). Operative variables and early postoperative outcomes (including bleeding, re-exploration, and 30-day mortality) were compared between the two groups. Results: The CCB group included 9 women and 21 men with a mean age of 59.5 ± 9.6 years, whereas the RCB group consisted of 5 women and 22 men with a mean age of 57.3 ± 8.9 years. The mean maximum aortic root diameter was 49.6 ± 5.3 mm, and the mean ascending aortic diameter was 50.8 ± 4.9 mm. Aortic cross-clamp (ACC) and cardiopulmonary bypass (CPB) times were similar between the groups (p = 0.330 and p = 0.214, respectively). After excluding patients who underwent planned coronary artery bypass grafting (CABG; n = 8), the incidence of unplanned CABG was higher in the CCB group than in the RCB group [6 (24.0%) vs. 2 (8.3%); p = 0.136]. Postoperative 24-h chest tube drainage tended to be lower (p = 0.060), and re-exploration for bleeding occurred less frequently (11.1% vs. 30.0%, p = 0.076), with no coronary button-related bleeding after reinforcement. The RCB group required significantly fewer transfused blood products, including red blood cells, fresh frozen plasma, and platelets (all p < 0.01). Intensive care unit stay was shorter in the reinforced group (p < 0.01), with a trend toward reduced hospital stay (p = 0.085). Early mortality was comparable (p = 0.356). Conclusions: Posterior Teflon-felt-reinforced coronary button anastomosis may improve early hemostatic stability and provide additional mechanical support during coronary reimplantation in the modified Bentall procedure; confirmation in larger cohorts is required.
- Open Access
- 18 May 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (10) , 1278
Sex-Specific Impact of Inflammation and Nutritional Indices on AVF Blood Flow and Maturation: A Retrospective Analysis
Background: Arteriovenous fistula (AVF) failure rates are consistently higher in females, although the underlying mechanisms remain incompletely understood. Inflammatory processes play a key role in AVF remodeling and venous arterialization, yet their influence may differ by sex. This study aimed to evaluate the impact of inflammatory indices on AVF blood flow and maturation, with a focus on sex-specific differences. Methods: This retrospective analytical study included 110 patients (50 females, 60 males) undergoing initial surgical AVF creation. Postoperative assessments occurred at the fourth and sixth weeks. Patients demonstrating insufficient maturation (blood flow < 600 mL/min) at the fourth week were re-evaluated after two weeks without any intervening procedures or additional interventions. Results: Intraoperative Transit-Time Flow Measurement (TTFM) revealed significantly higher median AVF blood flow in males compared to females (289 mL/min vs. 200 mL/min; p < 0.001). Doppler ultrasonography (DUS) findings confirmed these sex-related differences, demonstrating consistently lower blood flow rates in female patients. An elevated neutrophil-to-lymphocyte ratio (NLR) was associated with approximately a 31% reduction in AVF blood flow among females, whereas an increased C-reactive protein-to-albumin ratio (CrA) correlated with an approximate 9% decline. In males, an elevated systemic immune-inflammation index (SII) and systemic inflammation response index (SIRI) were significantly associated with decreased AVF blood flow. Conversely, a higher prognostic nutritional index (PNI) positively correlated with AVF blood flow in both sexes. Risk factors associated with inadequate AVF maturation (<600 mL/min at sixth week) included female sex, advanced age, obesity, smoking, anemia, low vitamin D levels, and elevated inflammatory indices (NLR, SII, and SIRI). Conclusions: Inflammatory and nutritional indices derived from routine laboratory tests may assist in estimating AVF maturation likelihood. While DUS reliably assesses AVF blood flow, complementary evaluation methods may be required to assess the broader vascular status. Further research is needed to clarify sex-specific inflammatory mechanisms influencing AVF outcomes and to guide individualized management strategies.
- 18 May 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (10) , 1278
Open AccessSex-Specific Impact of Inflammation and Nutritional Indices on AVF Blood Flow and Maturation: A Retrospective Analysis
Background: Arteriovenous fistula (AVF) failure rates are consistently higher in females, although the underlying mechanisms remain incompletely understood. Inflammatory processes play a key role in AVF remodeling and venous arterialization, yet their influence may differ by sex. This study aimed to evaluate the impact of inflammatory indices on AVF blood flow and maturation, with a focus on sex-specific differences. Methods: This retrospective analytical study included 110 patients (50 females, 60 males) undergoing initial surgical AVF creation. Postoperative assessments occurred at the fourth and sixth weeks. Patients demonstrating insufficient maturation (blood flow < 600 mL/min) at the fourth week were re-evaluated after two weeks without any intervening procedures or additional interventions. Results: Intraoperative Transit-Time Flow Measurement (TTFM) revealed significantly higher median AVF blood flow in males compared to females (289 mL/min vs. 200 mL/min; p < 0.001). Doppler ultrasonography (DUS) findings confirmed these sex-related differences, demonstrating consistently lower blood flow rates in female patients. An elevated neutrophil-to-lymphocyte ratio (NLR) was associated with approximately a 31% reduction in AVF blood flow among females, whereas an increased C-reactive protein-to-albumin ratio (CrA) correlated with an approximate 9% decline. In males, an elevated systemic immune-inflammation index (SII) and systemic inflammation response index (SIRI) were significantly associated with decreased AVF blood flow. Conversely, a higher prognostic nutritional index (PNI) positively correlated with AVF blood flow in both sexes. Risk factors associated with inadequate AVF maturation (<600 mL/min at sixth week) included female sex, advanced age, obesity, smoking, anemia, low vitamin D levels, and elevated inflammatory indices (NLR, SII, and SIRI). Conclusions: Inflammatory and nutritional indices derived from routine laboratory tests may assist in estimating AVF maturation likelihood. While DUS reliably assesses AVF blood flow, complementary evaluation methods may be required to assess the broader vascular status. Further research is needed to clarify sex-specific inflammatory mechanisms influencing AVF outcomes and to guide individualized management strategies.
- 1 September 2024
- Published by Clinics Cardive Publishing in CardioVascular Journal of Africa
- Vol. 35 (2) , 38-41
The effects on clinical outcomes of administering medications together or separately in prolonged dual antiplatelet therapy after peripheral revascularisation
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 35, No 2, May – August 2024 102 AFRICA The effects on clinical outcomes of administering medications together or
- 1 September 2024
- Published by Clinics Cardive Publishing in CardioVascular Journal of Africa
- Vol. 35 (2) , 38-41
The effects on clinical outcomes of administering medications together or separately in prolonged dual antiplatelet therapy after peripheral revascularisation
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 35, No 2, May – August 2024 102 AFRICA The effects on clinical outcomes of administering medications together or
- Open Access
- 28 May 2024
- Published by MediHealth Academy in Ankyra Medical Journal
- Vol. 3 (3) , 73-76
Treatment of recurrent pulmonary thromboembolism with ecosonic endovascular system
Venous thromboembolism is a collective term that describes two diseases, pulmonary thromboembolism (PTE) and deep vein thrombosis, with or without symptoms but often accompanying each other. Pulmonary thromboembolism (PTE) develops in most cases due to thrombus formation in the deep veins of the lower extremities and migrates to the pulmonary artery and/or its branches. It is a preventable disease with high mortality and morbidity and includes diagnostic difficulties. Recurrence may occur despite treatment in 5-23% of PTE cases. Patients may apply to the hospital with symptoms such as unexplained dyspnea, stabbing or atypical chest pain, hemoptysis, and syncope. We aimed to present the patient who had chronic deep vein thrombosis (DVT) and was frequently hospitalized due to recurrent massive PTE. In our case, disease status requires catheter thrombolytic therapies two times in three months.
- 28 May 2024
- Published by MediHealth Academy in Ankyra Medical Journal
- Vol. 3 (3) , 73-76
Open AccessTreatment of recurrent pulmonary thromboembolism with ecosonic endovascular system
Venous thromboembolism is a collective term that describes two diseases, pulmonary thromboembolism (PTE) and deep vein thrombosis, with or without symptoms but often accompanying each other. Pulmonary thromboembolism (PTE) develops in most cases due to thrombus formation in the deep veins of the lower extremities and migrates to the pulmonary artery and/or its branches. It is a preventable disease with high mortality and morbidity and includes diagnostic difficulties. Recurrence may occur despite treatment in 5-23% of PTE cases. Patients may apply to the hospital with symptoms such as unexplained dyspnea, stabbing or atypical chest pain, hemoptysis, and syncope. We aimed to present the patient who had chronic deep vein thrombosis (DVT) and was frequently hospitalized due to recurrent massive PTE. In our case, disease status requires catheter thrombolytic therapies two times in three months.
- Open Access
- 1 January 2024
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 28 (11) , 550-554
Predicting Postoperative Atrial Fibrillation Using HARMS2-AF Score
Background: Postoperative atrial fibrillation (POAF) remains a common complication after cardiac surgery. The ability to accurately identify patients at risk through previous risk scores is limited. This study aimed to evaluate the new HARMS2-AF risk score to predict POAF after coronary artery bypass grafting (CABG) surgery. Methods: In this retrospective cohort study, we included 265 patients undergoing CABG surgery from 2022-2023. Data were obtained from the medical files of the patients and hospital records. Each patient was assigned a HARMS2-AF risk score. A univariate and multivariate regression analyses were done to analyze independent predictors of POAF. Results: Of 265 patients, 49 had postoperative atrial fibrillation. HARMS2-AF score was significantly higher in patients with POAF. Age, sleep apnea,a left atrial diameter (LAd), and HARMS2-AF score were independently associated with POAF. A HARMS2-AF score ≥ 4.5 predicted POAF with 91% sensitivity and 64% specificity (AUC = 0.787, 95% CI = 0.731-0.842, P < .001). Conclusion: The HARMS2-AF score is a strong predictor of atrial fibrillation (AF) development after isolated CABG surgery. It can be used as a novel stratification tool to estimate AF after cardiac surgery.
- 1 January 2024
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 28 (11) , 550-554
Open AccessPredicting Postoperative Atrial Fibrillation Using HARMS2-AF Score
Background: Postoperative atrial fibrillation (POAF) remains a common complication after cardiac surgery. The ability to accurately identify patients at risk through previous risk scores is limited. This study aimed to evaluate the new HARMS2-AF risk score to predict POAF after coronary artery bypass grafting (CABG) surgery. Methods: In this retrospective cohort study, we included 265 patients undergoing CABG surgery from 2022-2023. Data were obtained from the medical files of the patients and hospital records. Each patient was assigned a HARMS2-AF risk score. A univariate and multivariate regression analyses were done to analyze independent predictors of POAF. Results: Of 265 patients, 49 had postoperative atrial fibrillation. HARMS2-AF score was significantly higher in patients with POAF. Age, sleep apnea,a left atrial diameter (LAd), and HARMS2-AF score were independently associated with POAF. A HARMS2-AF score ≥ 4.5 predicted POAF with 91% sensitivity and 64% specificity (AUC = 0.787, 95% CI = 0.731-0.842, P < .001). Conclusion: The HARMS2-AF score is a strong predictor of atrial fibrillation (AF) development after isolated CABG surgery. It can be used as a novel stratification tool to estimate AF after cardiac surgery.
- 21 August 2023
- Published by Mugla Sitki Kocman University in Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi
- Vol. 10 (2) , 110-114
Farklı Konsantrasyonlardaki Monosodyum Glutamatın Koryoallantoik Membran Modelinde Anti-Anjiyojenik ve Oksidan Etkileri
Objective: Monosodium glutamate (MSG) is a flavor enhancing food additive. MSG exposure is rising day by day because of the high commercial food consumption. MSG exposure causes damage to various tissues and organs. The aim of this study is to investigate the effects of MSG on angiogenesis and oxidant-antioxidant balance. Methods: Three different concentrations of MSG (10-4 M, 10-5 M, and 10-6 M), control, and the bevasizumab (10-6 M) were prepared and placed on the chorioallantoic membrane (CAM) of the embryos. Albumen was taken from the embryos before and after the experiment. Angiogenesis was investigated through the window that was opened on the eggshell. Results: Angiogenesis was found to be normal in the control and 10-6 M MSG group (average score:0.3). Anti-angiogenic effects were moderate in the 10-5 M MSG group (average score: 0.5) and in the 10-4 M MSG group (average score: 0.7), and strong in the bevasizumab group (average score: 1.1). Conclusion: According to our results MSG shows anti-angiogenic properties in higher doses. MSG increased oxidative stress. According to the results of our research, it is seen that MSG inhibits angiogenesis in a dose-dependent manner in the CAM model and may cause an increase in oxidative damage by disrupting the oxidant-antioxidant balance. Since no previous study has been found in the literature regarding the effects of MSG on angiogenesis and oxidant-antioxidant balance in the CAM model, we think that our results will fill an important gap in the literature.
- 21 August 2023
- Published by Mugla Sitki Kocman University in Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi
- Vol. 10 (2) , 110-114
Farklı Konsantrasyonlardaki Monosodyum Glutamatın Koryoallantoik Membran Modelinde Anti-Anjiyojenik ve Oksidan Etkileri
Objective: Monosodium glutamate (MSG) is a flavor enhancing food additive. MSG exposure is rising day by day because of the high commercial food consumption. MSG exposure causes damage to various tissues and organs. The aim of this study is to investigate the effects of MSG on angiogenesis and oxidant-antioxidant balance. Methods: Three different concentrations of MSG (10-4 M, 10-5 M, and 10-6 M), control, and the bevasizumab (10-6 M) were prepared and placed on the chorioallantoic membrane (CAM) of the embryos. Albumen was taken from the embryos before and after the experiment. Angiogenesis was investigated through the window that was opened on the eggshell. Results: Angiogenesis was found to be normal in the control and 10-6 M MSG group (average score:0.3). Anti-angiogenic effects were moderate in the 10-5 M MSG group (average score: 0.5) and in the 10-4 M MSG group (average score: 0.7), and strong in the bevasizumab group (average score: 1.1). Conclusion: According to our results MSG shows anti-angiogenic properties in higher doses. MSG increased oxidative stress. According to the results of our research, it is seen that MSG inhibits angiogenesis in a dose-dependent manner in the CAM model and may cause an increase in oxidative damage by disrupting the oxidant-antioxidant balance. Since no previous study has been found in the literature regarding the effects of MSG on angiogenesis and oxidant-antioxidant balance in the CAM model, we think that our results will fill an important gap in the literature.
- Open Access
- 20 August 2022
- Published by Acta Medica Alanya in Acta Medica Alanya
- Vol. 6 (2) , 179-184
The dose-dependent antiangiogenic potential of apixaban: an experimental outlook
Aim: Direct oral anticoagulants (DOACs) are good alternatives to conventional medical regimens for the treatment and prevention of thromboembolism. Apixaban is one of the more popular variations of these newly developed drugs. Aside from its anticoagulant potential, possible cellular effects remain a topic for future studies. The object of this study was to investigate the possible antiangiogenic effects of apixaban in the chorioallantoic membrane (CAM) model.Method: Drug pellets were prepared at 10-4, 10-5, and 10-6 M concentrations of apixaban and were placed in the chorioallantoic membrane on the fourth day of egg incubation. On the eighth day, all vascular densities of the membranes were compared with a 10-6 M concentration of bevacizumab, which is a known monoclonal, humanized, vascular endothelial growth-factor inhibitor.Results: We find that a 10-4 M concentration of apixaban has strong antiangiogenic potential similar to that of bevacizumab. However, there was moderate antiangiogenic potential at a lower dose of apixaban (10-5 M, 10-6 M). A comparison of the higher doses of antiangiogenic potential (10-4 M concentration) with lower doses of apixaban (10-5 M, 10-6 M) revealed significant statistical differences (p < 0.05).Conclusion: Our results indicate that a high dose of apixaban has strong antiangiogenic potential. The exact mechanism of this effect remains unknown. These pilot results should be confirmed with further studies to obtain an updated look at DOACs.
- 20 August 2022
- Published by Acta Medica Alanya in Acta Medica Alanya
- Vol. 6 (2) , 179-184
Open AccessThe dose-dependent antiangiogenic potential of apixaban: an experimental outlook
Aim: Direct oral anticoagulants (DOACs) are good alternatives to conventional medical regimens for the treatment and prevention of thromboembolism. Apixaban is one of the more popular variations of these newly developed drugs. Aside from its anticoagulant potential, possible cellular effects remain a topic for future studies. The object of this study was to investigate the possible antiangiogenic effects of apixaban in the chorioallantoic membrane (CAM) model.Method: Drug pellets were prepared at 10-4, 10-5, and 10-6 M concentrations of apixaban and were placed in the chorioallantoic membrane on the fourth day of egg incubation. On the eighth day, all vascular densities of the membranes were compared with a 10-6 M concentration of bevacizumab, which is a known monoclonal, humanized, vascular endothelial growth-factor inhibitor.Results: We find that a 10-4 M concentration of apixaban has strong antiangiogenic potential similar to that of bevacizumab. However, there was moderate antiangiogenic potential at a lower dose of apixaban (10-5 M, 10-6 M). A comparison of the higher doses of antiangiogenic potential (10-4 M concentration) with lower doses of apixaban (10-5 M, 10-6 M) revealed significant statistical differences (p < 0.05).Conclusion: Our results indicate that a high dose of apixaban has strong antiangiogenic potential. The exact mechanism of this effect remains unknown. These pilot results should be confirmed with further studies to obtain an updated look at DOACs.
- Open Access
- 10 May 2022
- Published by Polish Pharmaceutical Society in Acta Poloniae Pharmaceutica - Drug Research
- Vol. 79 (1) , 111-115
The investigation of possible beneficial effects of gabapentin on adverse cardiac effects of high dose zoledronic acid: an experimental study
- 10 May 2022
- Published by Polish Pharmaceutical Society in Acta Poloniae Pharmaceutica - Drug Research
- Vol. 79 (1) , 111-115
Open AccessThe investigation of possible beneficial effects of gabapentin on adverse cardiac effects of high dose zoledronic acid: an experimental study